New use for old drugs: Epirubicin in colorectal cancer

Authors

  • Line S. Tarpgaard Department of Oncology, Odense University Hospital, Odense, Denmark
  • Camilla Qvortrup Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
  • Signe L. Nielsen Faculty of Health and Medical Sciences, Institute of Drug Design and Pharmacology, University of Copenhagen, Frederiksberg, Denmark
  • Jan Stenvang Faculty of Health and Medical Sciences, Institute of Drug Design and Pharmacology, University of Copenhagen, Frederiksberg, Denmark
  • Sönke Detlefsen Department of Pathology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
  • Nils Brünner Faculty of Health and Medical Sciences, Institute of Drug Design and Pharmacology, University of Copenhagen, Frederiksberg, Denmark
  • Per Pfeiffer Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

DOI:

https://doi.org/10.1080/0284186X.2021.1904519

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2021-07-03

How to Cite

Tarpgaard, L. S., Qvortrup, C., Nielsen, S. L., Stenvang, J., Detlefsen, S., Brünner, N., & Pfeiffer, P. (2021). New use for old drugs: Epirubicin in colorectal cancer. Acta Oncologica, 60(7), 954–956. https://doi.org/10.1080/0284186X.2021.1904519

Issue

Vol. 60 No. 7 (2021): Acta Oncologica

Section

Articles